Lion Biotechnologies (LBIO) Tops Q3 EPS by 5c

Lion Biotechnologies (NASDAQ: LBIO) reported Q3 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22).

Lion anticipates the ending cash, cash equivalents and short-term investments as of December 31, 2016, to be in excess of $164.0 million.

For earnings history and earnings-related data on Lion Biotechnologies (LBIO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02